In this analysis, we investigated the prevalence of the LAG3 rs870849 allele and clinical outcome in a retrospective study of a B-cell lymphoma cohort treated with current anti-CD19 CAR T-cell therapies. This evidence concerns the gene CD19 and B-cell non-Hodgkin lymphoma.